|
Search
Collections
Benchmarks
Upload document
Product
Risperidone-SABER
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
1 indication
Indication
Schizophrenia
Clinical trial
A Pilot, Open-Label, Non-Randomized, Single Ascending Dose, Safety and Pharmacokinetic Trial With Injectable Risperidone-SABER and the DosePro Delivery System in Patients With Chronic, Stable Schizophrenia or Schizoaffective Disorder
Status: Completed
, Estimated PCD: 2013-04-01
